Trial intelligence / Profile preview

Crisaborole ointment for scrotal eczema

ChiCTR2100051499Phase 4Recruiting

Sponsor
Southern Medical University Dermatology Hospital
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of crisaborole in dermatitis (2 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: Eczema Area and Severity Index (EASI) score. Started Sep 2021; status: recruiting.

02

Drugs

crisaborole
03

Conditions

dermatitis

Beyond the preview

Go deeper on ChiCTR2100051499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100051499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call